Skip to main navigation Skip to search Skip to main content

No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

Translated title of the contribution: No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia
  • M.L. Grijsen
  • , R Holman
  • , L. Gras
  • , F.W. Wit
  • , A.I.M. Hoepelman
  • , G.E. van den Berk
  • , F. de Wolf
  • , J.M. Prins

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionNo advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia
Original languageUndefined/Unknown
Pages (from-to)1609-1613
Number of pages14
JournalAntiviral Therapy
Volume17
Issue number8
Publication statusPublished - 2012

Cite this